Skip to main navigation Skip to search Skip to main content

Eculizumab improves fatigue in refractory generalized myasthenia gravis

  • The REGAIN study group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2247-2254
Number of pages8
JournalQuality of Life Research
Volume28
Issue number8
DOIs
StatePublished - Aug 15 2019

ASJC Scopus Subject Areas

  • Public Health, Environmental and Occupational Health

Keywords

  • Complement
  • Eculizumab
  • Fatigue
  • Myasthenia gravis
  • Neuro-QOL Fatigue
  • Quality of life
  • Terminal complement inhibition

Cite this